Evidence map›Paper›PMID 30369203›Full record

ArticleZhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi2018

[The expression of CRLF2 in adult Ph negative acute B lymphocytic leukemia and its prognostic significance].

H Chen, X J Wang, S Liu, F F Yuan, H Ai, L Chen, R H Mi, Y Y Xiong, M J Li, R H Fan and 2 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact, top 65% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

H ChenDepartment of Hematology, the Affiliated Cancer Hospital of Zhengzhou University; Henan Cancer Hospital, Zhengzhou 450008, China.
X J Wang
S Liu
F F Yuan
H Ai
L Chen
R H Mi
Y Y Xiong
M J Li
R H Fan
Q S Yin
X D Wei
Henan Cancer Hospital · CN

Funding

Henan Provincial Medical Science and Technology Research Project 201701028Henan Provincial Natural Science Foundation 22180003
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Leukemia, B-CellPrecursor Cell Lymphoblastic Leukemia-LymphomaAdultDisease-Free SurvivalHumansPrognosisReceptors, CytokineRisk FactorsCRLF2 protein, humanReceptors, CytokineCRLF2 proteinLeukemia, B-cell, acutePrognosis

Identifiers

PMID30369203
PMCPMC7348285
OpenAlexW3025146810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.